These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

288 related articles for article (PubMed ID: 28470949)

  • 1. Loss of SH3GL2 promotes the migration and invasion behaviours of glioblastoma cells through activating the STAT3/MMP2 signalling.
    Zhu Y; Zhang X; Wang L; Ji Z; Xie M; Zhou X; Liu Z; Shi H; Yu R
    J Cell Mol Med; 2017 Nov; 21(11):2685-2694. PubMed ID: 28470949
    [TBL] [Abstract][Full Text] [Related]  

  • 2. IL-6 augments the invasiveness of U87MG human glioblastoma multiforme cells via up-regulation of MMP-2 and fascin-1.
    Li R; Li G; Deng L; Liu Q; Dai J; Shen J; Zhang J
    Oncol Rep; 2010 Jun; 23(6):1553-9. PubMed ID: 20428809
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MiR-330-mediated regulation of SH3GL2 expression enhances malignant behaviors of glioblastoma stem cells by activating ERK and PI3K/AKT signaling pathways.
    Yao Y; Xue Y; Ma J; Shang C; Wang P; Liu L; Liu W; Li Z; Qu S; Li Z; Liu Y
    PLoS One; 2014; 9(4):e95060. PubMed ID: 24736727
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SH3GL3 acts as a novel tumor suppressor in glioblastoma tumorigenesis by inhibiting STAT3 signaling.
    Nie Z; Cai S; Wei Z; Li Y; Bian L; Wang C; Wang X; Wang C
    Biochem Biophys Res Commun; 2021 Mar; 544():73-80. PubMed ID: 33524871
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MiR-338-5p Promotes Glioma Cell Invasion by Regulating TSHZ3 and MMP2.
    Li Y; Huang Y; Qi Z; Sun T; Zhou Y
    Cell Mol Neurobiol; 2018 Apr; 38(3):669-677. PubMed ID: 28780604
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SH3GL2 gene participates in MEK-ERK signal pathway partly by regulating EGFR in the laryngeal carcinoma cell line Hep2.
    Shang C; Guo Y; Fu S; Fu W; Sun K
    Med Sci Monit; 2010 Jun; 16(6):BR168-73. PubMed ID: 20512084
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SH3BGRL3, transcribed by STAT3, facilitates glioblastoma tumorigenesis by activating STAT3 signaling.
    Nie Z; Cheng D; Pan C; Wei Z; Wang C; Wang C
    Biochem Biophys Res Commun; 2021 Jun; 556():114-120. PubMed ID: 33839406
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stattic and metformin inhibit brain tumor initiating cells by reducing STAT3-phosphorylation.
    Leidgens V; Proske J; Rauer L; Moeckel S; Renner K; Bogdahn U; Riemenschneider MJ; Proescholdt M; Vollmann-Zwerenz A; Hau P; Seliger C
    Oncotarget; 2017 Jan; 8(5):8250-8263. PubMed ID: 28030813
    [TBL] [Abstract][Full Text] [Related]  

  • 9. NFATc1 activation promotes the invasion of U251 human glioblastoma multiforme cells through COX-2.
    Wang L; Wang Z; Li J; Zhang W; Ren F; Yue W
    Int J Mol Med; 2015 May; 35(5):1333-40. PubMed ID: 25738651
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Knockdown of Diaph1 expression inhibits migration and decreases the expression of MMP2 and MMP9 in human glioma cells.
    Zhang C; Wang L; Chen J; Liang J; Xu Y; Li Z; Chen F; Du D
    Biomed Pharmacother; 2017 Dec; 96():596-602. PubMed ID: 29035824
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MicroRNA-330 is an oncogenic factor in glioblastoma cells by regulating SH3GL2 gene.
    Qu S; Yao Y; Shang C; Xue Y; Ma J; Li Z; Liu Y
    PLoS One; 2012; 7(9):e46010. PubMed ID: 23029364
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Overexpression of Hsc70 promotes proliferation, migration, and invasion of human glioma cells.
    Sun G; Cao Y; Xu Y; Huai D; Chen P; Guo J; Li M; Dai Y
    J Cell Biochem; 2019 Jun; 120(6):10707-10714. PubMed ID: 30816582
    [TBL] [Abstract][Full Text] [Related]  

  • 13. GOLPH3 promotes glioblastoma cell migration and invasion via the mTOR-YB1 pathway in vitro.
    Zhang X; Ding Z; Mo J; Sang B; Shi Q; Hu J; Xie S; Zhan W; Lu D; Yang M; Bian W; Zhou X; Yu R
    Mol Carcinog; 2015 Nov; 54(11):1252-63. PubMed ID: 25156912
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Loss of Sh3gl2/endophilin A1 is a common event in urothelial carcinoma that promotes malignant behavior.
    Majumdar S; Gong EM; Di Vizio D; Dreyfuss J; Degraff DJ; Hager MH; Park PJ; Bellmunt J; Matusik RJ; Rosenberg JE; Adam RM
    Neoplasia; 2013 Jul; 15(7):749-60. PubMed ID: 23814487
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CXCR7 silencing inhibits the migration and invasion of human tumor endothelial cells derived from hepatocellular carcinoma by suppressing STAT3.
    Wu Y; Tian L; Xu Y; Zhang M; Xiang S; Zhao J; Wang Z
    Mol Med Rep; 2018 Aug; 18(2):1644-1650. PubMed ID: 29901083
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Silibinin downregulates MMP2 expression via Jak2/STAT3 pathway and inhibits the migration and invasive potential in MDA-MB-231 cells.
    Byun HJ; Darvin P; Kang DY; Sp N; Joung YH; Park JH; Kim SJ; Yang YM
    Oncol Rep; 2017 Jun; 37(6):3270-3278. PubMed ID: 28440514
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MiR-519a functions as a tumor suppressor in glioma by targeting the oncogenic STAT3 pathway.
    Hong L; Ya-Wei L; Hai W; Qiang Z; Jun-Jie L; Huang A; Song-Tao Q; Yun-Tao L
    J Neurooncol; 2016 May; 128(1):35-45. PubMed ID: 26970980
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Down-regulation of Stat3 decreases invasion activity and induces apoptosis of human glioma cells.
    Chen F; Xu Y; Luo Y; Zheng D; Song Y; Yu K; Li H; Zhang L; Zhong W; Ji Y
    J Mol Neurosci; 2010 Mar; 40(3):353-9. PubMed ID: 20069389
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of the JAK-2/STAT3 signaling pathway impedes the migratory and invasive potential of human glioblastoma cells.
    Senft C; Priester M; Polacin M; Schröder K; Seifert V; Kögel D; Weissenberger J
    J Neurooncol; 2011 Feb; 101(3):393-403. PubMed ID: 20589525
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Salidroside inhibits migration, invasion and angiogenesis of MDA‑MB 231 TNBC cells by regulating EGFR/Jak2/STAT3 signaling via MMP2.
    Kang DY; Sp N; Kim DH; Joung YH; Lee HG; Park YM; Yang YM
    Int J Oncol; 2018 Aug; 53(2):877-885. PubMed ID: 29901185
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.